Who
Shivpreet Singh Kapoor
Director
Company insider
Files Form 4 as: Director, Forte Biosciences.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Sep 2024
- Last trade
- 27 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —31,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,353 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —31,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,353 | filing |
| 29 May 2026filed 2 Jun 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,353 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,353 at $0.00 | filing |
| 20 Mar 2025filed 21 Mar 2025 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 17 Sep 2024filed 19 Sep 2024 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.